2015
DOI: 10.1074/jbc.m114.626929
|View full text |Cite
|
Sign up to set email alerts
|

The FBXL10/KDM2B Scaffolding Protein Associates with Novel Polycomb Repressive Complex-1 to Regulate Adipogenesis

Abstract: Background: Polycomb repressive complex PRC1 is an epigenetic regulator of cellular differentiation. However, its function during adipogenesis is unknown. Results: FBXL10/KDM2B recruited noncanonical PRC1 complex in F-box and LRR motifs dependent on cell cycle-related genes and Pparg genes and repressed 3T3-L1 adipogenesis. Conclusion: Noncanonical PRC1 complex containing FBXL10/KDM2B regulates adipogenesis. Significance: Our findings revealed a novel epigenetic mechanism of adipogenesis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
49
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 39 publications
(53 citation statements)
references
References 59 publications
4
49
0
Order By: Relevance
“…We first examined the distribution of KDM2B in the tissues of adult mice. KDM2B was highly expressed in the brain ( Fig EV1A) as previously reported (Inagaki et al, 2015). To investigate the role of KDM2B in skeletal muscle, we first checked its expression using a C2C12 myoblast cell line.…”
Section: Kdm2b Is Expressed In the Early Phase Of Skeletal Muscle Difsupporting
confidence: 56%
See 1 more Smart Citation
“…We first examined the distribution of KDM2B in the tissues of adult mice. KDM2B was highly expressed in the brain ( Fig EV1A) as previously reported (Inagaki et al, 2015). To investigate the role of KDM2B in skeletal muscle, we first checked its expression using a C2C12 myoblast cell line.…”
Section: Kdm2b Is Expressed In the Early Phase Of Skeletal Muscle Difsupporting
confidence: 56%
“…However, KDM2B can also decrease cancer cell proliferation by inhibiting the expression of oncogenes (Yan et al, 2018). Other than regulating cell proliferation and thereby tumor biology, KDM2B inhibits adipogenesis as part of polycomb repressive complex 1 (PRC1), but in a demethylaseindependent manner (Inagaki et al, 2015). However, the role of KDM2B histone demethylase in myogenic differentiation remains unknown.…”
mentioning
confidence: 99%
“…KDM2B contains multiple functional domains, including the JmjC histone demethylase domain, a DNA-binding CxxC zinc finger, an F-box domain, a PHD finger, and eight leucine-rich repeats (LRRs). The F-box and the LRR domain are required for variant polycomb repressor complex 1 (PRC1) recruitment and assembly (Farcas et al, 2012; He et al, 2013; Inagaki et al, 2015; Wu et al, 2013). To decipher how KDM2B exerts its function in cortical development, we carried out rescue experiments using in utero electroporation (Figure 6A-6D).…”
Section: Resultsmentioning
confidence: 99%
“…Interestingly, KDM2B-dependent adipogenesis inhibition is independent from the demethylase activity of the protein; however, its F-box and leucine-rich repeat domains are required for recruiting a noncanonical PRC1 containing the RING1B, SKP1, PCGF1, and BCOR proteins [75].…”
Section: Kdm2 Cluster (Fbxl Subfamily)mentioning
confidence: 99%